首页> 美国卫生研究院文献>The Journal of Biological Chemistry >Evidence That Does Not Support Pyruvate Kinase M2 (PKM2)-catalyzed Reaction as a Rate-limiting Step in Cancer Cell Glycolysis
【2h】

Evidence That Does Not Support Pyruvate Kinase M2 (PKM2)-catalyzed Reaction as a Rate-limiting Step in Cancer Cell Glycolysis

机译:不支持丙酮酸激酶M2(PKM2)催化反应作为癌细胞糖酵解中的限速步骤的证据

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

It has been recognized that the rate-limiting function of pyruvate kinase M2 (PKM2) in glycolysis plays an important role in distributing glycolytic intermediates for anabolic and catabolic purposes in cancer cells. However, after analysis of the catalytic capacity of PKM2 relative to other glycolytic enzymes, the regulation range of PKM2 activity, metabolic flux control, and thermodynamics, we suggest that the PKM2-catalyzed reaction is not a rate-limiting step in cancer cell glycolysis. Hexokinase and phosphofructokinase 1 (PFK1), the first and third enzyme along the pathway, are rate-limiting enzymes that limit the overall glycolytic rate, whereas PKM2 and lactate dehydrogenase, the last two enzymes in the pathway, are for the fast removal of upstream intermediates to prevent the obstruction of the pathway. The argument is in accordance with the catalytic capacity of glycolytic enzymes, regulation range of enzyme activities, metabolic flux control, and thermodynamics.
机译:已经认识到丙酮酸激酶M2(PKM2)在糖酵解中的限速功能在为癌细胞中的合成代谢和分解代谢目的分配糖酵解中间体中起重要作用。但是,在分析了PKM2相对于其他糖酵解酶的催化能力,PKM2活性的调节范围,代谢通量控制和热力学之后,我们认为PKM2催化的反应不是癌细胞糖酵解中的限速步骤。己糖激酶和磷酸果糖激酶1(PFK1)是该途径中的第一个和第三个酶,是限制总糖酵解速率的限速酶,而PKM2和乳酸脱氢酶是该途径中的后两个酶,用于快速清除上游防止通路阻塞的中间体。论据是根据糖酵解酶的催化能力,酶活性的调节范围,代谢通量控制和热力学来确定的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号